Drugs News and Research

RSS

House Democrats criticize recent increases in brand-name drug prices

The Wall Street Journal: "Reports of prescription drug-price increases have congressional Democrats complaining about price gouging and questioning whether drug companies are reneging on a pledge to provide billions of savings as part of a U.S. health-care overhaul sought by President Barack Obama.

8 Dec 2009

Reuters news examines quest for new TB drugs, vaccines

Reuters examines the search for new tuberculosis medicines and vaccines. "Although TB has plagued humankind for thousands of years, there is only one vaccine," which isn't very effective and doesn't protect adults. "With the exception of rifabutin, there has been no new drug for TB for more than 40 years," the news service writes.

8 Dec 2009

RIVA System effective in automatically compounding IV doses in syringes with minimal contamination

A recent study demonstrated the RIVA System (Robotic Intravenous Automation) - a self-contained unit for aseptic compounding from Intelligent Hospital Systems (IH Systems) - is an effective tool in automatically compounding IV doses in syringes and bags with minimal drug contamination.

8 Dec 2009

Drug reimportation emerges again in health debate

The Hill reports that Senate Majority Leader Harry Reid "has agreed to allow Sen. Byron Dorgan (D-N.D.) to bring an amendment to a vote this week that would allow the importation of cheaper prescription drugs from abroad despite the fact that it could blow up a truce between the White House, Senate Finance Committee Chairman Max Baucus (D-Mont.) and the Pharmaceutical Research and Manufacturers of America (PhRMA) on healthcare reform." Sen. Olympia Snowe (R-Maine) is among the amendment's co-sponsors.

8 Dec 2009

QuantRx Biomedical launches its new flagship POC diagnostic reader device at MEDICA 2009

QuantRx® Biomedical Corporation, a broad-based diagnostic company focused on the development and commercialization of innovative diagnostic products, announced today the successful debut of its new flagship point-of-care (POC) diagnostic reader device, Q-Reader™, at MEDICA 2009 on November 18-21, 2009, in Düsseldorf, Germany.

8 Dec 2009

Rib-X Pharmaceuticals, Yale University expand agreement to explore new ribosome technology

Rib-X Pharmaceuticals, Inc., a company focused on the discovery, development and commercialization of novel drugs for the treatment of serious multi-drug-resistant infections, announced today it has entered into a further license agreement with Yale University in the area of ribosome and antibiotic structure and function.

8 Dec 2009

BHR Pharma files an IND for its BHR-100 intravenous progesterone infusion product

BHR Pharma, LLC (BHR) announced today that it has filed an Investigational New Drug (IND) application with the U.S. Food and Drug Administration (FDA) for its proprietary BHR-100 intravenous progesterone infusion product.

8 Dec 2009

Brazil: The largest emerging pharmaceutical market for hepatitis C virus

Decision Resources, one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare issues, finds that at approximately $120 million, the hepatitis C virus drug market in Brazil is among the largest emerging pharmaceutical markets for the disease.

8 Dec 2009

First Edition: December 8, 2009

Today's headlines highlight how Senate consideration of the health bill could become even messier with amendments pending on abortion funding restrictions and the reimportation of prescription drugs. All the while, Senate Dems continue to work to find common ground on the public option.

8 Dec 2009

Tranzyme Pharma and Bristol-Myers Squibb sign collaboration agreement

Tranzyme Pharma today announced that it has entered into a strategic collaboration agreement with Bristol-Myers Squibb Company to discover, develop and commercialize novel macrocyclic compounds directed against targets of interest to Bristol-Myers Squibb.

8 Dec 2009

Enrollment of patients for Phase I/IIa clinical study of Interleukin-7 commenced

Cytheris SA, a clinical stage biopharmaceutical company focused on research and development of new therapies for immune modulation, today announced that it has begun enrolling patients in its Phase I/IIa clinical program evaluating the company’s investigative immune-modulator, recombinant human Interleukin-7 (CYT107), in combination with standard antiviral treatment and vaccination in HBeAg-negative chronic hepatitis B-infected (HBV) patients.

8 Dec 2009

CML patients on nilotinib or dasatinib drug achieve better response than imatinib drug

Two medications approved as treatment for drug-resistant chronic myeloid leukemia continue to provide patients with quicker, better responses as a first treatment than the existing front-line drug, researchers at The University of Texas M. D. Anderson Cancer Center reported at the 51st Annual Meeting of the American Society of Hematology.

8 Dec 2009

Positive data from Onconova Therapeutics' ON 01910.Na trial for advanced MDS

Onconova Therapeutics, Inc. today announced promising results from two clinical trials in patients with advanced Myelodysplastic Syndrome (MDS) treated with ON 01910.Na. These trials are being conducted at the National Heart, Lung, and Blood Institute (NHLBI) in Bethesda, MD, and St. Vincent’s Comprehensive Cancer Center in New York.

8 Dec 2009

CeNeRx BioPharma's TriRima reversibly inhibits MAO-A, confirms PET imaging study

CeNeRx BioPharma, Inc., a clinical stage company developing innovative treatments for diseases of the central nervous system, today announced that a newly published PET imaging study in human subjects confirms that CeNeRx's novel compound TriRima(TM) reversibly inhibits MAO-A (monoamine oxidase A), an enzyme in the brain that plays a key role in the regulation of mood.

8 Dec 2009

Discovery may lead to new treatments for late-stage breast cancer

Researchers from the Indiana University School of Medicine and colleagues at the University of Texas Southwestern and Case Western University have determined how the protein Mdm2, which is elevated in late-stage cancers, disables genes that suppress the growth of tumors. The finding may lead to the development of new drugs for late stage breast cancer and other difficult to treat malignancies.

8 Dec 2009

Social support groups offer effective ways to tackle domestic violence

A new group at Queen's University Belfast will help tackle the scourge of domestic violence, which affects thousands of women, children and men in Northern Ireland every day.

8 Dec 2009

LCA-GA praises Senators' support in establishing comprehensive program for lung cancer

Today, Lung Cancer Alliance-Georgia (LCA-GA) acknowledged Senators Saxby Chambliss (R-GA) and Johnny Isakson (R-GA) for their leadership and support in establishing the first ever multi-agency, comprehensive program targeted at lung cancer.

8 Dec 2009

Generic erosion of premium-priced branded agents to offset sales of new agents

Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that generic erosion of premium-priced branded agents will offset sales of new agents and will cause the acute coronary syndrome market for drugs in the hospital setting to decrease from $800 million in 2008 to $729 million in 2018 in the United States, France, Germany, Italy, Spain, the United Kingdom and Japan.

8 Dec 2009

Market for personalized medicine in the United States to grow 11 percent annually, shows report

The market for personalized medicine in the United States is already $232 billion, and it is projected to grow 11 percent annually, according to a new report published today by PricewaterhouseCoopers LLP, entitled The Science of Personalized Medicine: Translating the Promise into Practice.

8 Dec 2009

Study: Besides nerves, skin has a unique sensory system

The human sensory experience is far more complex and nuanced than previously thought, according to a groundbreaking new study published in the December 15, 2009 issue of the journal Pain (http://www.painjournalonline.com/article/S0304-3959%2809%2900526-0/abstract).

8 Dec 2009

Drugs News and Research

House Democrats criticize recent increases in brand-name drug prices

Reuters news examines quest for new TB drugs, vaccines

RIVA System effective in automatically compounding IV doses in syringes with minimal contamination

Drug reimportation emerges again in health debate

QuantRx Biomedical launches its new flagship POC diagnostic reader device at MEDICA 2009

Rib-X Pharmaceuticals, Yale University expand agreement to explore new ribosome technology

BHR Pharma files an IND for its BHR-100 intravenous progesterone infusion product

Brazil: The largest emerging pharmaceutical market for hepatitis C virus

First Edition: December 8, 2009

Tranzyme Pharma and Bristol-Myers Squibb sign collaboration agreement

Enrollment of patients for Phase I/IIa clinical study of Interleukin-7 commenced

CML patients on nilotinib or dasatinib drug achieve better response than imatinib drug

Positive data from Onconova Therapeutics' ON 01910.Na trial for advanced MDS

CeNeRx BioPharma's TriRima reversibly inhibits MAO-A, confirms PET imaging study

Discovery may lead to new treatments for late-stage breast cancer

Social support groups offer effective ways to tackle domestic violence

LCA-GA praises Senators' support in establishing comprehensive program for lung cancer

Generic erosion of premium-priced branded agents to offset sales of new agents

Market for personalized medicine in the United States to grow 11 percent annually, shows report

Study: Besides nerves, skin has a unique sensory system

Drug Discovery - Second Edition eBook

Leveraging the power of automation to boost research

Automating research - solutions and best practices

How can microdialysis benefit drug development

Latest News